We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info . X close

Endoscopic Ultrasonography (EUS) Market: Growth, Size, Share, and Trends

Report Code MD 9316
Published in Feb, 2025, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Endoscopic Ultrasonography (EUS) Market by Product (Endoscopes, Ultrasound Processors, Ultrasound Needles, Probes), Type (Diagnostic, Therapeutic), Application (Oncology, GI, End User (Hospitals, Ambulatory Surgical Center) - Global Forecast to 2029

Overview

The global endoscopic ultrasonography market, valued at US$1.28 billion in 2023, is forecasted to grow at a robust CAGR of 7.1%, reaching US$1.37 billion in 2024 and an impressive US$1.93 billion by 2029. The growth in the endoscopic ultrasonography market can be attributed to the factors, including increasing investments, funds, and grants by governments and other organizations, rising focus of hospitals to expand endoscopic ultrasonography units and bring advancements in endoscopic ultrasonography technologies. At the same time, high costs of endoscopic ultrasonography procedures can restrain the growth of this market during the forecast period.

Endoscopic Ultrasonography Market– Global Forecast and Key Opportunities to 2029

Attractive Opportunities in the Endoscopic Ultrasonography Market

Asia Pacific

Growth in the APAC market can be attributed to the increasing cancer patient volume, increasing healthcare expenditure, rapidly developing healthcare infrastructure, growing geriatric population, and increasing prevalence of chronic diseases in this region.

The market's expansion is primarily fueled by factors such as the rising favor towards minimally invasive surgeries and the increased demand for advanced endoscopic ultrasound devices.

Collaborations, partnerships, and agreements are poised to present attractive growth prospects for market participants in the foreseeable future.

In 2023, the US accounted for the largest share of 89.3% of the North American endoscopic ultrasound market.

The market's expansion is primarily fueled by factors such growing prevalence of gastrointestinal diseases, expanding healthcare infrastructure, and rising investments by government.

Global Endoscopic Ultrasonography Market Dynamics

DRIVER: Growing focus of hospitals to invest in technologically advanced endoscopic ultrasonography devices

Hospitals are increasingly prioritizing investments in technologically advanced endoscopic ultrasonography devices and expanding their endoscopic ultrasonography units. This trend is driven by the increasing benefits offered by technologically advanced endoscopic ultrasonography devices in improving diagnostic accuracy and treatment outcomes. With a focus on enhancing patient care and staying at the forefront of medical innovation, hospitals are allocating resources to upgrade their endoscopic ultrasonography diagnostics capabilities, meeting the rising demand for minimally invasive procedures. For instance, in October 2023, Mayo Clinic announced a significant investment in innovative endoscopic equipment, aiming to enhance their diagnostic capabilities and expand their endoscopy units to meet growing patient demand for minimally invasive procedures.

RESTRAINT: High costs of endoscopic ultrasonography procedures to hinder market growth

The high costs involved in endoscopic ultrasonography procedures become a significant challenge for the healthcare systems within the developing countries. The expenses are high due to factors such as equipping, maintenance, and training of personnel. This makes the process costly for the healthcare facilities to render their services for endoscopic ultrasonography. The other factor causing further strain is the low reimbursement rates, which makes it extremely difficult for the healthcare providers to run their operations effectively. This situation usually results in inequalities in the distribution of endoscopic ultrasonography diagnostic services, where most patients cannot afford such procedures and hence prevent proper diagnosis and therapy.

The endoscopic ultrasonographys are very crucial in diagnosis and treatment of all kinds of medical conditions, but access is limited by financial constraints in developing countries. To bridge this gap, the policymakers, healthcare providers, and stakeholders develop sustainable reimbursement models, spend money on cost-effective devices, and further expand the reach of affordable endoscopic ultrasonography services to reach the developing countries.

 

OPPORTUNITY: Expansion of healthcare sector in developing regions

The healthcare sector of the developing economies is growing at a fast pace due to various reasons. With rapid urbanization and a burgeoning middle-class population, there is an ever-growing awareness regarding healthcare, which fuels the demand for quality medical services. Governments have also channeled funds toward establishing healthcare infrastructure and technology to increase accessibility and affordability to healthcare. Moreover, newer trends in medical treatment and the arrival of novel healthcare solutions are powerful growth drivers for these economies. Thus, the healthcare sector in developing countries is growing at a profound rate, providing ample opportunities for healthcare practitioners, investment, and medical technology businesses. Additionally, medical tourism has been a boon for some developing countries, which in turn has led to more demand for more sophisticated diagnostic solutions like endoscopic ultrasonographys for accurate and efficient treatment, furthermore creating a very good opportunity for market growth.

CHALLENGES: Shortage of trained physicians and endoscopists

Trained physicians and endoscopists scarcity challenges the market in endoscopic ultrasonography. With increasing demands for endoscopic procedures, the scarcity of the right professionals constrains the effective usage of highly developed equipment in endoscopic ultrasonography in diagnosis and treatment procedures for gastrointestinal disorders. The lack of such a significant number of experts has restricted the pace of delivery of healthcare services, besides impeding the pace of technological development in endoscopic ultrasonographys and hence growth of the market.

Global Endoscopic Ultrasonography Market Ecosystem Analysis

The ecosystem of the endoscopic ultrasonography market comprises elements present in this market and defines these elements with a demonstration of the bodies involved. It includes manufacturers, distributors, research & product developers, regulatory bodies, and end users. The ecosystem of the overall endoscopic ultrasonography market comprises the different elements and subdivisions present in it. Manufacturers include the organizations that are involved in the entire process of research, product development, optimization, and launch. Distributors include third parties and eCommerce sites, which are linked with organizations for the marketing.

Endoscopic Ultrasonography Market Ecosystem
 

Endoscopes segment accounted for the largest share in the endoscopic ultrasonography market by product.

The endoscopes segment accounted for the largest share of the global endoscopic ultrasonography market in the forecast period. Rising demand for technologically advanced endoscopes that provide high-resolution images and increasing prevalence of chronic diseases such as cancer and gastrointestinal disorders boost the demand for endoscopes. Additionally, the major players in the endoscopic ultrasonography market, such as Olympus Corporation (Japan), FUJIFILM Holdings Corporation (Japan), and Boston Scientific Corporation (US) continuously invest in research and development of innovative endoscopes. This ensures a continuous supply of advanced technologies to meet the evolving needs of the market.

Diagnostics segment accounted for the largest share in the endoscopic ultrasonography market by type.

The dominance of the diagnostics segment in the endoscopic ultrasonography market is attributed to several factors. Firstly, there's a rising incidence of gastrointestinal disorders globally, necessitating increased diagnostic procedures. Additionally, advancements in endoscopic ultrasonography technologies have led to improved imaging quality and efficiency in endoscopic procedures, further driving the demand for endoscopic ultrasonography equipment. Moreover, the preference for minimally invasive procedures among patients and healthcare providers further boost the segment's market share.

Oncology segment accounted for the largest share in the endoscopic ultrasonography market by application.

The oncology segment accounted for the largest share of the global endoscopic ultrasonography market owing to the increasing prevalence of gastrointestinal cancers such as pancreatic, colorectal, and esophagus because endoscopic ultrasonography devices provide high-resolution images that help in early detection and accurate staging for a successful treatment. Moreover, growing awareness for early detection of cancer and preference for minimally invasive techniques further fuel the market growth.

Hospital segment accounted for the largest share in the endoscopic ultrasonography market by end user.

The hospital segment dominates in the endoscopic ultrasonography market due to the large volume of medical procedures conducted within their facilities. With a rising demand for advanced endoscopic ultrasonography procedures, hospitals are expected to invest in innovative endoscopic equipment. Moreover, hospitals comprise of specialized departments for gastroenterology, and oncology with experienced professionals for performing endoscopic ultrasonography procedures thereby further driving the segmental growth. Thus, all these factors contribute to the overall growth of endoscopic ultrasonography market.

North America segment accounted for the largest share in the medical device cleaning market by Region.

North America dominates the endoscopic ultrasonography market, primarily due to its advanced healthcare infrastructure, widespread adoption of medical technologies, and a growing incidence of gastrointestinal diseases. Moreover, the region's well-established healthcare facilities increasingly adopt endoscopic procedures and equipment coupled with favorable reimbursement policies boost the growth for the endoscopic ultrasonography market.

HIGHEST CAGR MARKET IN 2023
US FASTEST GROWING MARKET IN THE REGION
Endoscopic Ultrasonography Market Region

Recent Developments of Endoscopic Ultrasonography Market

  • In September 2024, Olympus Corporation launched a new 4K camera head1, CH-S700-08-LB, for endoscopic urology and gynecology procedures in Europe.
  • In December 2023, Medtronic expanded its partnership with Cosmo Intelligent Medical Devices, a Cosmo Pharmaceuticals subsidiary, leveraging AI for the GI Genius endoscopy module.

Key Market Players

Want to explore hidden markets that can drive new revenue in Endoscopic Ultrasonography (EUS) Market?

Scope of the Report

Report Metric Details
Market size available for years 2024-2029
Base Year Considered 2023
Forecast period 2024-2029
Forecast units Value (USD Million/Billion)
Segments covered Product, Type, Application, End User, and Region
Geographies covered North America (US & Canada), Europe (Germany, UK, France, Italy, Spain, and RoE), APAC (Japan, China, Australia, South Korea, India, and the RoAPAC), LATAM (Brazil, Mexico, and RoLATAM), Middle East & Africa (GCC countries)

 

Key Questions Addressed by the Report

What are the drivers of endoscopic ultrasonography market?
The drivers of the endoscopic ultrasonography market include increasing prevalnce of chronic diseases such as gastrointestinal disorders, and cancer, rising demand of advanced endoscopic technologies, and growing preference for minimally invasive surgeries to drive market growth.
Which product dominates the endoscopic ultrasonography market?
The endoscopes segment, by product is dominating the endoscopic ultrasonography market.
Who are the end users of the endoscopic ultrasonography market? Which end user is leading the market?
The endoscopic ultrasonography market is segmented into hospitals, ambulatory surgical centers, and others (diagnostic centers & specialty clinics). The hospitals segment accounted for the largest share of the endoscopic ultrasonography market in 2023.
Who are the key players in the endoscopic ultrasonography market?
The key players in the endoscopic ultrasonography market are Olympus Corporation (Japan), Medtronic (US), FUJIFILM Holdings Corporation (Japan), Boston Scientific Corporation (US), PENTAX Medical (Japan), and Steris (Ireland).
Which region is lucrative for the endoscopic ultrasonography market?
The Asia Pacific market is expected to witness the highest growth during the forecast period.

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Endoscopic Ultrasonography (EUS) Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
29
RESEARCH METHODOLOGY
33
EXECUTIVE SUMMARY
49
PREMIUM INSIGHTS
53
MARKET OVERVIEW
57
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Increasing requirement for endoscopy procedures to diagnose and treat target diseases
    - Rising incidence of gastrointestinal disorders and colorectal cancer
    - Increased investments, funds, and grants by government bodies and other organizations
    - Technological advancements in ENDOSCOPIC ULTRASONOGRAPHY (EUS) devices
    RESTRAINTS
    - High costs of ENDOSCOPIC ULTRASONOGRAPHY (EUS) procedures
    - Complications and limitations of ENDOSCOPIC ULTRASONOGRAPHY (EUS)
    OPPORTUNITIES
    - High market growth potential in emerging economies
    - Increasing preference for minimally invasive surgeries
    CHALLENGES
    - Increasing number of product recalls
  • 5.3 INDUSTRY TRENDS
    ULTRASOUND CAPSULE ENDOSCOPY
    ENDOSCOPIC ULTRASONOGRAPHY (EUS)-GUIDED SHEAR WAVE ELASTOGRAPHY
  • 5.4 VALUE CHAIN ANALYSIS
  • 5.5 SUPPLY CHAIN ANALYSIS
  • 5.6 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Contrast-enhanced ENDOSCOPIC ULTRASONOGRAPHY (EUS)
    - Lumen-apposing metal stents
    COMPLEMENTARY TECHNOLOGIES
    - Elastography
  • 5.7 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.8 KEY STAKEHOLDERS & BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    KEY BUYING CRITERIA
  • 5.9 REGULATORY ANALYSIS
    REGULATORY FRAMEWORK
    - North America
    - Europe
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.10 PRICING ANALYSIS
    AVERAGE SELLING PRICE TREND OF ENDOSCOPIC ULTRASONOGRAPHY (EUS) PRODUCTS, BY KEY PLAYER, 2021–2023
    AVERAGE SELLING PRICE TREND OF ENDOSCOPIC ULTRASONOGRAPHY (EUS) PRODUCTS, BY REGION, 2021–2023
  • 5.11 ECOSYSTEM ANALYSIS
    ROLE IN ECOSYSTEM
  • 5.12 PATENT ANALYSIS
    PATENT PUBLICATION TRENDS FOR ENDOSCOPIC ULTRASONOGRAPHY (EUS)
    INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
  • 5.13 TRADE ANALYSIS
    IMPORT DATA FOR HS CODE 901890
    EXPORT DATA FOR HS CODE 901890
  • 5.14 KEY CONFERENCES & EVENTS, 2025–2026
  • 5.15 UNMET NEEDS/END-USER EXPECTATIONS
  • 5.16 IMPACT OF AI/GEN AI ON ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET
  • 5.17 CASE STUDY ANALYSIS
  • 5.18 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
  • 5.19 ADJACENT MARKETS
  • 5.20 INVESTMENT & FUNDING SCENARIO
ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY PRODUCT
95
  • 6.1 INTRODUCTION
  • 6.2 ENDOSCOPES
    RADIAL ENDOSCOPES
    - High image quality, improved penetration depth, and excellent maneuverability to propel segment growth
    LINEAR ENDOSCOPES
    - Improved real-time targeting of lesions and better clinical management to aid segment growth
  • 6.3 ULTRASOUND PROCESSORS
    ULTRASOUND PROCESSORS TO PRECISELY DETECT ABNORMALITIES AND FACILITATE BETTER TREATMENT PLANNING
  • 6.4 ULTRASOUND PROBES
    CONSTANT INNOVATIONS AND ADVANCEMENTS TO AUGMENT MARKET GROWTH
  • 6.5 ULTRASOUND NEEDLES
    FINE NEEDLE ASPIRATION
    - Superior accuracy and effectiveness in staging cancer to fuel segment growth
    FINE NEEDLE BIOPSIES
    - Improved diagnostic accuracy in pancreatic and non-pancreatic lesions to boost segment growth
    OTHER ULTRASOUND NEEDLES
  • 6.6 ACCESSORIES
    INCREASING ADOPTION OF ACCESSORIES FOR BETTER EFFICIENCY, PRECISION, AND SAFETY OF PROCEDURES TO DRIVE MARKET
ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY TYPE
111
  • 7.1 INTRODUCTION
  • 7.2 DIAGNOSTICS
    RISING PREVALENCE OF GASTROINTESTINAL DISEASES TO PROPEL MARKET GROWTH
  • 7.3 THERAPEUTICS
    INCREASING ADOPTION OF MINIMALLY INVASIVE PROCEDURES FOR PANCREATIC DISORDERS TO AID SEGMENT GROWTH
ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY APPLICATION
115
  • 8.1 INTRODUCTION
  • 8.2 ONCOLOGY
    UPPER GASTROINTESTINAL ONCOLOGY
    - Increasing incidence of esophageal and gastric cancers to drive segment
    LOWER GASTROINTESTINAL ONCOLOGY
    - High prevalence of colorectal cancer to support segment growth
  • 8.3 GASTROINTESTINAL DISORDERS
    PANCREATIC DISORDERS
    - Rising burden of chronic pancreatic diseases to aid segment growth
    OTHER GASTROINTESTINAL DISORDERS
  • 8.4 OTHER APPLICATIONS
ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY END USER
127
  • 9.1 INTRODUCTION
  • 9.2 HOSPITALS
    INCREASED DEMAND FOR ADVANCED IMAGING TECHNIQUES AND PRECISE DIAGNOSTICS TO SPUR MARKET GROWTH
  • 9.3 AMBULATORY SURGERY CENTERS
    COST-EFFECTIVENESS AND HIGH REIMBURSEMENT RATES TO PROPEL MARKET GROWTH
  • 9.4 OTHER END USERS
ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY REGION
133
  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    US
    - US to dominate North American ENDOSCOPIC ULTRASONOGRAPHY (EUS) market during forecast period
    CANADA
    - Rising incidence of cancer and increasing focus on early disease detection to propel market growth
  • 10.3 EUROPE
    MACROECONOMIC OUTLOOK FOR EUROPE
    GERMANY
    - Increased healthcare spending and favorable research initiatives to spur market growth
    UK
    - High government healthcare funding to support market growth
    FRANCE
    - Advancements in healthcare and favorable national health insurance to fuel market growth
    ITALY
    - Rising geriatric population and increasing focus on cancer care to propel market growth
    SPAIN
    - High prevalence of lifestyle-related cancer risk and increased healthcare expenditure to augment market growth
    REST OF EUROPE
  • 10.4 ASIA PACIFIC
    MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    JAPAN
    - Favorable government health insurance schemes and high geriatric population to aid market growth
    CHINA
    - Large patient pool and high obesity rates to drive market
    INDIA
    - Increasing prevalence of cancer and improved government healthcare initiatives to aid market growth
    SOUTH KOREA
    - High incidence of gastrointestinal diseases and cancer among aged population to fuel market growth
    AUSTRALIA
    - Increased patient volume and favorable government initiatives to drive market
    REST OF ASIA PACIFIC
  • 10.5 LATIN AMERICA
    MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    BRAZIL
    - High risk of chronic diseases among geriatric population to propel market growth
    MEXICO
    - Improved healthcare infrastructure and increased cancer awareness to augment market growth
    REST OF LATIN AMERICA
  • 10.6 MIDDLE EAST & AFRICA
    MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    GCC COUNTRIES
    - Increasing healthcare infrastructure development and investment to support market growth
    REST OF MIDDLE EAST AND AFRICA
COMPETITIVE LANDSCAPE
221
  • 11.1 INTRODUCTION
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET
  • 11.3 REVENUE ANALYSIS, 2019–2023
  • 11.4 MARKET SHARE ANALYSIS, 2023
  • 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2023
    - Company footprint
    - Region footprint
    - Product footprint
    - Type footprint
    - Application footprint
    - End-user footprint
  • 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
    - Detailed list of key startups/SMEs
    - Competitive benchmarking of key startups/SMEs
  • 11.7 COMPANY VALUATION & FINANCIAL METRICS
  • 11.8 BRAND/PRODUCT COMPARISON
  • 11.9 R&D ASSESSMENT OF KEY PLAYERS
  • 11.10 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES & APPROVALS
    EXPANSIONS
    DEALS
    OTHER DEVELOPMENTS
COMPANY PROFILES
246
  • 12.1 KEY PLAYERS
    OLYMPUS CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    MEDTRONIC
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    FUJIFILM HOLDINGS CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    BOSTON SCIENTIFIC CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    PENTAX MEDICAL
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    STERIS
    - Business overview
    - Products offered
    - Recent developments
    CONMED CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.
    - Business overview
    - Products offered
    - Recent developments
    CANON MEDICAL SYSTEMS CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    COOK
    - Business overview
    - Products offered
    - Recent developments
  • 12.2 OTHER PLAYERS
    HUACO HEALTHCARE TECHNOLOGIES CO., LTD.
    SONOSCAPE MEDICAL CORP.
    ENDOSOUND, INC.
    LIMACA-MEDICAL
    BEIJING ZKSK TECHNOLOGY CO., LTD.
    KAIGEN PHARMA CO., LTD.
    PIOLAX MEDICAL DEVICES, INC.
    MICRO-TECH ENDOSCOPY
    SHAILI ENDOSCOPY
    ZHEJIANG SOUDON MEDICAL TECHNOLOGY CO., LTD.
    ENDO-FLEX GMBH
    ACE MEDICAL DEVICES PVT. LTD.
    MEDI-GLOBE GMBH
    MEDORAH MEDITEK PVT. LTD.
    INNERMEDICAL CO., LTD.
APPENDIX
298
  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET: INCLUSIONS & EXCLUSIONS
  • TABLE 2 STANDARD CURRENCY CONVERSION RATES (USD)
  • TABLE 3 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET: STUDY ASSUMPTIONS
  • TABLE 4 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET: RISK ASSESSMENT
  • TABLE 5 US: ESTIMATED NUMBER OF NEW COLORECTAL CANCER CASES, BY AGE AND SEX (2023)
  • TABLE 6 MAJOR DEVELOPMENTS IN FUNDING ORGANIZATIONS, JANUARY 2021–DECEMBER 2024
  • TABLE 7 GENERIC DIAGNOSTIC ENDOSCOPIC ULTRASONOGRAPHY (EUS) PROCEDURE COST IN ALBERTA, CANADA (2023)
  • TABLE 8 COST OF RECTAL ENDOSCOPIC ULTRASONOGRAPHY (EUS) FOR US (2023)
  • TABLE 9 COMPANY EXPANSIONS IN EMERGING ECONOMIES
  • TABLE 10 LIST OF PRODUCT RECALLS BY KEY PLAYERS, 2020–2022
  • TABLE 11 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET: PORTER’S FIVE FORCES
  • TABLE 12 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS
  • TABLE 13 KEY BUYING CRITERIA FOR TOP THREE END USERS
  • TABLE 14 REGULATORY STANDARDS/APPROVALS REQUIRED FOR ENDOSCOPY, BY COUNTRY
  • TABLE 15 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 AVERAGE SELLING PRICE TREND OF ENDOSCOPIC ULTRASONOGRAPHY (EUS) PRODUCTS, BY KEY PLAYER, 2021–2023
  • TABLE 19 AVERAGE SELLING PRICE TREND OF ENDOSCOPIC ULTRASONOGRAPHY (EUS) PRODUCTS, BY REGION, 2021–2023
  • TABLE 20 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET: ROLE IN ECOSYSTEM
  • TABLE 21 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET: LIST OF PATENTS/PATENT APPLICATIONS, JANUARY 2021–DECEMBER 2024
  • TABLE 22 IMPORT DATA FOR HS CODE 901890, BY COUNTRY, 2019–2023 (USD THOUSAND)
  • TABLE 23 EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2019–2023 (USD THOUSAND)
  • TABLE 24 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025–DECEMBER 2026
  • TABLE 25 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET: UNMET NEEDS/END-USER EXPECTATIONS
  • TABLE 26 DEVELOPMENT OF ADVANCED SYSTEMS BY OLYMPUS CORPORATION TO ENHANCE MANAGEMENT OF GASTROINTESTINAL AND PANCREATICOBILIARY DISEASES
  • TABLE 27 USE OF SLIM LINEAR ECHOENDOSCOPE IN EUS PROCEDURES BY PENTAX MEDICAL
  • TABLE 28 USE OF SHARKCORE FNB NEEDLE BY MEDTRONIC TO FACILITATE DIAGNOSTIC YIELD IN EUS-GUIDED BIOPSIES
  • TABLE 29 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 30 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR ENDOSCOPES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 31 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR ENDOSCOPES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 32 RADIAL ENDOSCOPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 33 LINEAR ENDOSCOPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 34 ENDOSCOPIC ULTRASONOGRAPHY (EUS) PROCESSORS MARKET, BY REGION, 2022–2029 (THOUSAND UNITS)
  • TABLE 35 ENDOSCOPIC ULTRASONOGRAPHY (EUS) PROCESSORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 36 ENDOSCOPIC ULTRASONOGRAPHY (EUS) PROBES MARKET, BY REGION, 2022–2029 (THOUSAND UNITS)
  • TABLE 37 ENDOSCOPIC ULTRASONOGRAPHY (EUS) PROBES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 38 ENDOSCOPIC ULTRASONOGRAPHY (EUS) NEEDLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 39 ENDOSCOPIC ULTRASONOGRAPHY (EUS) NEEDLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 40 FINE NEEDLE ASPIRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 41 FINE NEEDLE BIOPSIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 42 OTHER ULTRASOUND NEEDLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 43 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR ACCESSORIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 44 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY TYPE 2022–2029 (USD MILLION)
  • TABLE 45 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 46 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR THERAPEUTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 47 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY APPLICATION 2022–2029 (USD MILLION)
  • TABLE 48 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR ONCOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 49 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 50 UPPER GASTROINTESTINAL ONCOLOGY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 51 LOWER GASTROINTESTINAL ONCOLOGY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 52 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 53 NUMBER OF PROCEDURES FOR GASTROINTESTINAL DISORDERS, BY REGION, 2023 (THOUSAND/MILLION)
  • TABLE 54 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR GASTROINTESTINAL DISORDERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 55 PANCREATIC DISORDERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 56 OTHER GASTROINTESTINAL DISORDERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 57 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 58 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 59 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 60 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 61 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 62 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 63 NORTH AMERICA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 64 NORTH AMERICA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 65 NORTH AMERICA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR ENDOSCOPES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 66 NORTH AMERICA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) NEEDLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 67 NORTH AMERICA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 68 NORTH AMERICA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 69 NORTH AMERICA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 70 NORTH AMERICA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 71 NORTH AMERICA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 72 MEDICARE NATIONAL AVERAGE COVERAGE FOR OUTPATIENT PROCEDURES, 2024
  • TABLE 73 US: KEY MACROINDICATORS
  • TABLE 74 US: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 75 US: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR ENDOSCOPES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 76 US: ENDOSCOPIC ULTRASONOGRAPHY (EUS) NEEDLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 77 US: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 78 US: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 79 US: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 80 US: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 81 US: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 82 CANADA: KEY MACROINDICATORS
  • TABLE 83 CANADA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 84 CANADA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR ENDOSCOPES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 85 CANADA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) NEEDLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 86 CANADA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 87 CANADA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 88 CANADA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 89 CANADA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 90 CANADA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 91 EUROPE: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 92 EUROPE: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 93 EUROPE: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR ENDOSCOPES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 94 EUROPE: ENDOSCOPIC ULTRASONOGRAPHY (EUS) NEEDLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 95 EUROPE: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 96 EUROPE: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 97 EUROPE: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 98 EUROPE: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 99 EUROPE: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 100 GERMANY: KEY MACROINDICATORS
  • TABLE 101 GERMANY: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 102 GERMANY: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR ENDOSCOPES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 103 GERMANY: ENDOSCOPIC ULTRASONOGRAPHY (EUS) NEEDLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 104 GERMANY: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 105 GERMANY: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 106 GERMANY: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 107 GERMANY: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 108 GERMANY: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 109 UK: KEY MACROINDICATORS
  • TABLE 110 UK: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 111 UK: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR ENDOSCOPES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 112 UK: ENDOSCOPIC ULTRASONOGRAPHY (EUS) NEEDLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 113 UK: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 114 UK: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 115 UK: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 116 UK: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 117 UK: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 118 FRANCE: KEY MACROINDICATORS
  • TABLE 119 FRANCE: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 120 FRANCE: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR ENDOSCOPES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 121 FRANCE: ENDOSCOPIC ULTRASONOGRAPHY (EUS) NEEDLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 122 FRANCE: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 123 FRANCE: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 124 FRANCE: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 125 FRANCE: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 126 FRANCE: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 127 ITALY: KEY MACROINDICATORS
  • TABLE 128 ITALY: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 129 ITALY: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR ENDOSCOPES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 130 ITALY: ENDOSCOPIC ULTRASONOGRAPHY (EUS) NEEDLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 131 ITALY: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 132 ITALY: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 133 ITALY: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 134 ITALY: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 135 ITALY: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 136 SPAIN: KEY MACROINDICATORS
  • TABLE 137 SPAIN: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 138 SPAIN: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR ENDOSCOPES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 139 SPAIN: ENDOSCOPIC ULTRASONOGRAPHY (EUS) NEEDLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 140 SPAIN: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 141 SPAIN: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 142 SPAIN: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 143 SPAIN: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 144 SPAIN: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 145 REST OF EUROPE: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 146 REST OF EUROPE: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR ENDOSCOPES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 147 REST OF EUROPE: ENDOSCOPIC ULTRASONOGRAPHY (EUS) NEEDLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 148 REST OF EUROPE: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 149 REST OF EUROPE: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 150 REST OF EUROPE: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 151 REST OF EUROPE: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 152 REST OF EUROPE: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 153 ASIA PACIFIC: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 154 ASIA PACIFIC: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 155 ASIA PACIFIC: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR ENDOSCOPES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 156 ASIA PACIFIC: ENDOSCOPIC ULTRASONOGRAPHY (EUS) NEEDLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 157 ASIA PACIFIC: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 158 ASIA PACIFIC: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 159 ASIA PACIFIC: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 160 ASIA PACIFIC: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 161 ASIA PACIFIC: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 162 JAPAN: KEY MACROINDICATORS
  • TABLE 163 JAPAN: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 164 JAPAN: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR ENDOSCOPES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 165 JAPAN: ENDOSCOPIC ULTRASONOGRAPHY (EUS) NEEDLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 166 JAPAN: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 167 JAPAN: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 168 JAPAN: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 169 JAPAN: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 170 JAPAN: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 171 CHINA: KEY MACROINDICATORS
  • TABLE 172 CHINA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 173 CHINA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR ENDOSCOPES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 174 CHINA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) NEEDLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 175 CHINA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 176 CHINA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 177 CHINA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 178 CHINA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 179 CHINA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 180 INDIA: KEY MACROINDICATORS
  • TABLE 181 INDIA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 182 INDIA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR ENDOSCOPES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 183 INDIA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) NEEDLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 184 INDIA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 185 INDIA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 186 INDIA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 187 INDIA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 188 INDIA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 189 SOUTH KOREA: KEY MACROINDICATORS
  • TABLE 190 SOUTH KOREA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 191 SOUTH KOREA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR ENDOSCOPES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 192 SOUTH KOREA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) NEEDLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 193 SOUTH KOREA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 194 SOUTH KOREA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 195 SOUTH KOREA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 196 SOUTH KOREA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 197 SOUTH KOREA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 198 AUSTRALIA: KEY MACROINDICATORS
  • TABLE 199 AUSTRALIA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 200 AUSTRALIA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR ENDOSCOPES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 201 AUSTRALIA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) NEEDLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 202 AUSTRALIA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 203 AUSTRALIA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 204 AUSTRALIA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 205 AUSTRALIA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 206 AUSTRALIA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 207 REST OF ASIA PACIFIC: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 208 REST OF ASIA PACIFIC: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR ENDOSCOPES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 209 REST OF ASIA PACIFIC: ENDOSCOPIC ULTRASONOGRAPHY (EUS) NEEDLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 210 REST OF ASIA PACIFIC: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 211 REST OF ASIA PACIFIC: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 212 REST OF ASIA PACIFIC: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 213 REST OF ASIA PACIFIC: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 214 REST OF ASIA PACIFIC: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 215 LATIN AMERICA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 216 LATIN AMERICA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 217 LATIN AMERICA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR ENDOSCOPES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 218 LATIN AMERICA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) NEEDLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 219 LATIN AMERICA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 220 LATIN AMERICA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 221 LATIN AMERICA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 222 LATIN AMERICA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 223 LATIN AMERICA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 224 BRAZIL: KEY MACROINDICATORS
  • TABLE 225 BRAZIL: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 226 BRAZIL: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR ENDOSCOPES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 227 BRAZIL: ENDOSCOPIC ULTRASONOGRAPHY (EUS) NEEDLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 228 BRAZIL: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 229 BRAZIL: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 230 BRAZIL: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 231 BRAZIL: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 232 BRAZIL: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 233 MEXICO: KEY MACROINDICATORS
  • TABLE 234 MEXICO: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 235 MEXICO: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR ENDOSCOPES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 236 MEXICO: ENDOSCOPIC ULTRASONOGRAPHY (EUS) NEEDLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 237 MEXICO: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 238 MEXICO: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 239 MEXICO: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 240 MEXICO: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 241 MEXICO: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 242 REST OF LATIN AMERICA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 243 REST OF LATIN AMERICA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR ENDOSCOPES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 244 REST OF LATIN AMERICA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) NEEDLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 245 REST OF LATIN AMERICA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 246 REST OF LATIN AMERICA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 247 REST OF LATIN AMERICA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 248 REST OF LATIN AMERICA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 249 REST OF LATIN AMERICA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 250 MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 251 MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 252 MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR ENDOSCOPES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 253 MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) NEEDLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 254 MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 255 MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 256 MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 257 MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 258 MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 259 GCC COUNTRIES: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 260 GCC COUNTRIES: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR ENDOSCOPES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 261 GCC COUNTRIES: ENDOSCOPIC ULTRASONOGRAPHY (EUS) NEEDLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 262 GCC COUNTRIES: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 263 GCC COUNTRIES: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 264 GCC COUNTRIES: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 265 GCC COUNTRIES: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 266 GCC COUNTRIES: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 267 REST OF MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 268 REST OF MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR ENDOSCOPES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 269 REST OF MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) NEEDLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 270 REST OF MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 271 REST OF MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 272 REST OF MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 273 REST OF MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 274 REST OF MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 275 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET
  • TABLE 276 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET: DEGREE OF COMPETITION
  • TABLE 277 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET: REGION FOOTPRINT
  • TABLE 278 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET: PRODUCT FOOTPRINT
  • TABLE 279 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET: TYPE FOOTPRINT
  • TABLE 280 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET: APPLICATION FOOTPRINT
  • TABLE 281 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET: END-USER FOOTPRINT
  • TABLE 282 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 283 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • TABLE 284 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–DECEMBER 2024
  • TABLE 285 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET: EXPANSIONS, JANUARY 2021–DECEMBER 2024
  • TABLE 286 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET: DEALS, JANUARY 2021–DECEMBER 2024
  • TABLE 287 OLYMPUS CORPORATION: COMPANY OVERVIEW
  • TABLE 288 OLYMPUS CORPORATION: PRODUCTS OFFERED
  • TABLE 289 OLYMPUS CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–DECEMBER 2024
  • TABLE 290 OLYMPUS CORPORATION: DEALS, JANUARY 2021–DECEMBER 2024
  • TABLE 291 OLYMPUS CORPORATION: EXPANSIONS, JANUARY 2021–DECEMBER 2024
  • TABLE 292 MEDTRONIC: COMPANY OVERVIEW
  • TABLE 293 MEDTRONIC: PRODUCTS OFFERED
  • TABLE 294 MEDTRONIC: PRODUCT APPROVALS, JANUARY 2021–DECEMBER 2024
  • TABLE 295 MEDTRONIC: DEALS, JANUARY 2021–DECEMBER 2024
  • TABLE 296 MEDTRONIC: EXPANSIONS, JANUARY 2021–DECEMBER 2024
  • TABLE 297 FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW
  • TABLE 298 FUJIFILM HOLDINGS CORPORATION: PRODUCTS OFFERED
  • TABLE 299 FUJIFILM HOLDINGS CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–DECEMBER 2024
  • TABLE 300 FUJIFILM HOLDINGS CORPORATION: DEALS, JANUARY 2021–DECEMBER 2024
  • TABLE 301 FUJIFILM HOLDINGS CORPORATION: OTHER DEVELOPMENTS, JANUARY 2021–DECEMBER 2024
  • TABLE 302 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
  • TABLE 303 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
  • TABLE 304 BOSTON SCIENTIFIC CORPORATION: PRODUCT APPROVALS, JANUARY 2021–DECEMBER 2024
  • TABLE 305 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2021–DECEMBER 2024
  • TABLE 306 PENTAX MEDICAL: COMPANY OVERVIEW
  • TABLE 307 PENTAX MEDICAL: PRODUCTS OFFERED
  • TABLE 308 PENTAX MEDICAL: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–DECEMBER 2024
  • TABLE 309 PENTAX MEDICAL: DEALS, JANUARY 2021−DECEMBER 2024
  • TABLE 310 STERIS: COMPANY OVERVIEW
  • TABLE 311 STERIS: PRODUCTS OFFERED
  • TABLE 312 STERIS: DEALS, JANUARY 2021–DECEMBER 2024
  • TABLE 313 STERIS: EXPANSIONS, JANUARY 2021–DECEMBER 2024
  • TABLE 314 CONMED CORPORATION: COMPANY OVERVIEW
  • TABLE 315 CONMED CORPORATION: PRODUCTS OFFERED
  • TABLE 316 CONMED CORPORATION: DEALS, JANUARY 2021–DECEMBER 2024
  • TABLE 317 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: COMPANY OVERVIEW
  • TABLE 318 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: PRODUCTS OFFERED
  • TABLE 319 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: PRODUCT APPROVALS, JANUARY 2021–DECEMBER 2024
  • TABLE 320 CANON MEDICAL SYSTEMS CORPORATION: COMPANY OVERVIEW
  • TABLE 321 CANON MEDICAL SYSTEMS CORPORATION: PRODUCTS OFFERED
  • TABLE 322 CANON MEDICAL SYSTEMS CORPORATION: DEALS, JANUARY 2021–DECEMBER 2024
  • TABLE 323 COOK: COMPANY OVERVIEW
  • TABLE 324 COOK: PRODUCTS OFFERED
  • TABLE 325 COOK: PRODUCT LAUNCHES, JANUARY 2021–DECEMBER 2024
  • TABLE 326 COOK: DEALS, JANUARY 2021–DECEMBER 2024
  • TABLE 327 COOK: EXPANSIONS, JANUARY 2021–DECEMBER 2024
  • TABLE 328 HUACO HEALTHCARE TECHNOLOGIES CO., LTD.: COMPANY OVERVIEW
  • TABLE 329 SONOSCAPE MEDICAL CORP.: COMPANY OVERVIEW
  • TABLE 330 ENDOSOUND, INC.: COMPANY OVERVIEW
  • TABLE 331 LIMACA-MEDICAL: COMPANY OVERVIEW
  • TABLE 332 BEIJING ZKSK TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
  • TABLE 333 KAIGEN PHARMA CO., LTD.: COMPANY OVERVIEW
  • TABLE 334 PIOLAX MEDICAL DEVICES, INC.: COMPANY OVERVIEW
  • TABLE 335 MICRO-TECH ENDOSCOPY: COMPANY OVERVIEW
  • TABLE 336 SHAILI ENDOSCOPY: COMPANY OVERVIEW
  • TABLE 337 ZHEJIANG SOUDON MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
  • TABLE 338 ENDO-FLEX GMBH: COMPANY OVERVIEW
  • TABLE 339 ACE MEDICAL DEVICES PVT. LTD.: COMPANY OVERVIEW
  • TABLE 340 MEDI-GLOBE GMBH: COMPANY OVERVIEW
  • TABLE 341 MEDORAH MEDITEK PVT. LTD.: COMPANY OVERVIEW
  • TABLE 342 INNERMEDICAL CO., LTD.: COMPANY OVERVIEW
LIST OF FIGURES
 
  • FIGURE 1 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET: MARKET SEGMENTATION AND GEOGRAPHICAL SPREAD
  • FIGURE 2 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET: YEARS CONSIDERED
  • FIGURE 3 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET: RESEARCH DESIGN
  • FIGURE 4 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET: KEY DATA FROM SECONDARY SOURCES
  • FIGURE 5 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET: KEY PRIMARY SOURCES
  • FIGURE 6 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET: KEY DATA FROM PRIMARY SOURCES
  • FIGURE 7 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET: KEY INSIGHTS FROM PRIMARIES
  • FIGURE 8 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND OTHER PARTICIPANTS
  • FIGURE 9 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 10 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
  • FIGURE 11 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS
  • FIGURE 12 REVENUE SHARE ANALYSIS ILLUSTRATION: OLYMPUS CORPORATION (2023)
  • FIGURE 13 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET: TOP-DOWN APPROACH
  • FIGURE 14 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET: SUPPLY-SIDE ANALYSIS (2023)
  • FIGURE 15 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 16 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET: CAGR PROJECTIONS
  • FIGURE 17 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET: DATA TRIANGULATION
  • FIGURE 18 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
  • FIGURE 19 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 20 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 21 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 22 GEOGRAPHICAL SNAPSHOT OF ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET
  • FIGURE 23 RISING PREVALENCE OF CANCER AND INCREASING POPULARITY OF MINIMALLY INVASIVE PROCEDURES TO DRIVE MARKET
  • FIGURE 24 CHINA AND HOSPITALS SEGMENTS COMMANDED LARGEST SHARE IN ASIA PACIFIC ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET IN 2023
  • FIGURE 25 JAPAN TO WITNESS HIGHEST GROWTH RATE FROM 2024 TO 2029
  • FIGURE 26 ASIA PACIFIC TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 27 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING STUDY PERIOD
  • FIGURE 28 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 29 SHARE OF SURGEONS PERFORMING OVER 100 ENDOSCOPIC PROCEDURES PER YEAR GLOBALLY, BY REGION (2024)
  • FIGURE 30 NUMBER OF ANNUAL PLANNED SESSIONS PER INDIVIDUAL IN UK (2021)
  • FIGURE 31 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 32 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 33 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET: PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 34 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS
  • FIGURE 35 KEY BUYING CRITERIA FOR TOP THREE END USERS
  • FIGURE 36 AVERAGE SELLING PRICE OF ENDOSCOPIC ULTRASONOGRAPHY (EUS) PRODUCTS, BY TYPE (2023)
  • FIGURE 37 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 38 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET: NUMBER OF GRANTED PATENT APPLICATIONS (JANUARY 2014–DECEMBER 2024)
  • FIGURE 39 TOP APPLICANTS/OWNERS (COMPANIES/INSTITUTIONS) FOR ENDOSCOPIC ULTRASONOGRAPHY (EUS) PATENTS (JANUARY 2014–DECEMBER 2024)
  • FIGURE 40 TOP APPLICANT COUNTRIES/REGIONS FOR ENDOSCOPIC ULTRASONOGRAPHY (EUS) PATENTS (JANUARY 2014–DECEMBER 2024)
  • FIGURE 41 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET: IMPACT OF AI/GEN AI
  • FIGURE 42 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
  • FIGURE 43 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET: ADJACENT MARKETS
  • FIGURE 44 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET: INVESTMENT/VENTURE CAPITAL SCENARIO (2019–2024)
  • FIGURE 45 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET REGIONAL SNAPSHOT
  • FIGURE 46 NORTH AMERICA: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET SNAPSHOT
  • FIGURE 47 ASIA PACIFIC: ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET SNAPSHOT
  • FIGURE 48 MARKET SHARE ANALYSIS OF PLAYERS IN ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET (2023)
  • FIGURE 49 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 50 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET: COMPANY FOOTPRINT
  • FIGURE 51 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 52 EV/EBITDA OF KEY VENDORS
  • FIGURE 53 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 54 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 55 ENDOSCOPIC ULTRASONOGRAPHY (EUS) MARKET: R&D ASSESSMENT OF KEY PLAYERS (2021–2023)
  • FIGURE 56 OLYMPUS CORPORATION: COMPANY SNAPSHOT
  • FIGURE 57 MEDTRONIC: COMPANY SNAPSHOT
  • FIGURE 58 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT
  • FIGURE 59 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • FIGURE 60 STERIS: COMPANY SNAPSHOT
  • FIGURE 61 CONMED CORPORATION: COMPANY SNAPSHOT
  • FIGURE 62 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: COMPANY SNAPSHOT
  • FIGURE 63 CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT

This study involved four major activities in estimating the current endoscopic ultrasonography market size. Exhaustive secondary research was done to collect information on the market, peer market and parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Business, Factiva, and D&B Hoovers), white papers, annual reports, companies house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the endoscopic ultrasonography market. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations operating in the endoscopic ultrasonography market. The primary sources from the demand side included industry experts, purchase & sales managers, doctors, and personnel from research organizations. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends and key market dynamics.

A breakdown of the primary respondents for the endoscopic ultrasonography market is provided below:

Endoscopic Ultrasonography Market

C-level primaries include CEOs, CFOs, COOs, and VPs.

*Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = < USD 1.00 billion.

Source: MarketsandMarkets Analysis

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global endoscopic ultrasonography market. All the major product manufacturers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/sub-segments was done for the major players. Also, the global endoscopic ultrasonography market was split into various segments and sub-segments based on:

  • List of major players operating in the products market at the regional and/or country level
  • Product mapping of various Endoscopic ultrasonographymanufacturers at the regional and/or country level
  • Mapping of annual revenue generated by listed major players from endoscopic ultrasonography market (or the nearest reported business unit/product category)
  • Revenue mapping of major players to cover at least 70-75% of the global market share as of 2023
  • Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
  • Summation of the market value of all segments/subsegments to arrive at the global endoscopic ultrasonography market

The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

Market Size Estimation (Bottom-Up approach & Top- down approach)

Endoscopic Ultrasonography Market

Data Triangulation

After arriving at the overall size of the global endoscopic ultrasonography market through the above-mentioned methodology, this market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both demand- and supply-side participants.

Market Definition

Endoscopic ultrasonography (EUS) is a medical procedure that combines endoscopy and ultrasound to obtain detailed images of the digestive tract, surrounding tissues, and nearby organs. It is widely used in the diagnosis, staging, and treatment of various gastrointestinal (GI) and thoracic conditions.

Stakeholders

  • Manufacturers of endoscopic ultrasonography
  • Endoscopic ultrasonography device distributors
  • Healthcare service providers
  • Various research associations related to endoscopic ultrasonography
  • Research institutes
  • Venture capitalists and investors
  • Various research and consulting companies
  • World Health Organization (WHO)
  • Organization for Economic Co-operation and Development (OECD)
  • National Institutes of Health (NIH)
  • Centers for Disease Control and Prevention (CDC)
  • Annual Reports/SEC Filings, Investor Presentations, and Press Releases of Key Players
  • White Papers, Journals/Magazines, and News Articles
  • Paid Databases, such as Factiva, D&B Hoovers, and Bloomberg Business  

Report Objectives

  • To define, describe, segment, and forecast the endoscopic ultrasonography market, by product, type, application & end user, and region.
  • To provide detailed information about the factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall endoscopic ultrasonography market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the endoscopic ultrasonography market in five main regions (along with their respective key countries), namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To profile the key players in the endoscopic ultrasonography market and comprehensively analyze their core competencies and market shares
  • To track and analyze competitive developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships are the principal growth strategies adopted by market players in the endoscopic ultrasonography market

Previous Versions of this Report

"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.


By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Endoscopic Ultrasonography (EUS) Market

DMCA.com Protection Status